Affordable Access

Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer.

Authors
  • Maestu, I
  • Gómez-Aldaraví, L
  • Torregrosa, M D
  • Camps, C
  • Llorca, C
  • Bosch, C
  • Gómez, J
  • Giner, V
  • Oltra, A
  • Albert, A
Type
Published Article
Journal
Lung Cancer
Publisher
Elsevier
Publication Date
Dec 01, 2003
Volume
42
Issue
3
Pages
345–354
Identifiers
PMID: 14644523
Source
Medline
License
Unknown

Abstract

The combination carboplatin-gemcitabine at these doses is feasible in elderly patients with advanced non-small cell lung cancer. Tolerability and toxicity are acceptable. Response rate and survival stand in the range of the most active regimens. Comorbidity and PS showed prognostic independence.

Report this publication

Statistics

Seen <100 times